Anticancer effects of tanshinone I in human non-small cell lung cancer

• Published in: Molecular cancer therapeutics Vol. 7; no. 11; pp. 3527 - 3538
• Main Authors: Lee, Chen-Yu, Sher, Hui-Fang, Chen, Huei-Wen, Liu, Chun-Chi, Chen, Ching-Hsien, Lin, Choun-Sea, Yang, Pan-Chyr, Tsay, Hsin-Sheng, Chen, Jeremy J W
• Format: Journal Article
• Language: English
• Published: United States American Association for Cancer Research 01.11.2008
• Subjects: Animals; Antineoplastic Agents, Phytogenic - pharmacology; Apoptosis; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - pathology; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes, Abietane; Humans; inflammation; Interleukin-8 - genetics; Interleukin-8 - metabolism; lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - pathology; metastasis; Mice; Mice, SCID; Models, Biological; Neoplasm Metastasis - pathology; NF-κB; Phenanthrenes - pharmacology; RNA, Messenger - metabolism; tanshinone; tumorigenesis
• ISSN: 1535-7163; 1538-8514
• DOI: 10.1158/1535-7163.MCT-07-2288

Tanshinones are the major bioactive compounds of Salvia miltiorrhiza Bunge (Danshen) roots, which are used in many therapeutic remedies in Chinese traditional medicine. We investigated the anticancer effects of tanshinones on the highly invasive human lung adenocarcinoma cell line, CL1-5. Tanshinone I significantly inhibited migration, invasion, and gelatinase activity in macrophage-conditioned medium-stimulated CL1-5 cells in vitro and also reduced the tumorigenesis and metastasis in CL1-5-bearing severe combined immunodeficient mice. Unlike tanshinone IIA, which induces cell apoptosis, tanshinone I did not have direct cytotoxicity. Real-time quantitative PCR, luciferase reporter assay, and electrophoretic mobility shift assay revealed that tanshinone I reduces the transcriptional activity of interleukin-8, the angiogenic factor involved in cancer metastasis, by attenuating the DNA-binding activity of activator protein-1 and nuclear factor-κB in conditioned medium-stimulated CL1-5 cells. Microarray and pathway analysis of tumor-related genes identified the differentially expressed genes responding to tanshinone I, which may be associated with the Ras-mitogen-activated protein kinase and Rac1 signaling pathways. These results suggest that tanshinone I exhibits anticancer effects both in vitro and in vivo and that these effects are mediated at least partly through the interleukin-8, Ras-mitogen-activated protein kinase, and Rac1 signaling pathways. Although tanshinone I has a remarkable anticancer action, its potential anticoagulant effect should be noted and evaluated. [Mol Cancer Ther 2008;7(11):3527–38]